Peter Marks, MD, PhD
·
4 Min Read

FDA’s Dr. Marks among 7 honored by AMA for work amid pandemic

Dr. Marks helped assure safety, efficacy of COVID-19 vaccines and kept physicians up to date. Learn about the other AMA award honorees.

Awards
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Feb. 14, 2022

In the news: 1-in-4 women experience domestic violence, CDC weighing updated mask guidance, vaccinated mothers share COVID-19 protection with their infants and more.

Publications & Newsletters
Person receiving a booster shot
·
4 Min Read

Are you boosted? If you’re eligible, now’s the time to act

As physicians, we play a critical role in assuring patients that COVID-19 booster shots are not only safe and effective, but absolutely necessary.

series
Leadership
Leadership Viewpoints
Coronavirus cell under magnifying glass
·
10 Min Read

What doctors wish patients knew about breakthrough COVID infections

The rapid spread of the SARS-CoV-2 Omicron variant has led to more fully vaccinated patients acquiring COVID-19. Learn why that happens and how boosters help.

series
Infectious Diseases
What Doctors Wish Patients Knew™
4 Min Read

COVID-19 vaccines: Pfizer-BioNTech

Pfizer-BioNTech COVID-19 vaccine is the first COVID-19 vaccine and first mRNA to receive full FDA approval and is being marketed as Comirnaty.

Infectious Diseases
3 Min Read

COVID-19 vaccines: Moderna

Moderna received emergency use authorization (EUA) by the FDA for their mRNA vaccine for COVID-19 on Dec. 20, 2020.

Infectious Diseases
3 Min Read

COVID-19 vaccines: Janssen/Johnson & Johnson

The Johnson & Johnson/Janssen (J&J) SARS-CoV-2 viral vector vaccine is the third COVID-19 vaccine authorized by FDA to help prevent more severe COVID-19 outcomes, including hospitalizations and death.

Infectious Diseases
Smiling child
·
4 Min Read

Unvaccinated kids at much higher risk of severe MIS-C outcomes

New research sheds light on the protective benefits afforded to children by COVID-19 vaccination. Omicron brings urgency to need for booster doses.

Population Health
Person wearing a mask giving a thumbs up
·
4 Min Read

COVID-19 vaccines: What FDA sees in latest data on boosters, kids

The FDA’s Peter Marks, MD, PhD, weighs in on boosters’ efficacy against the Delta variant and what’s coming next on vaccination for children under 5.

Infectious Diseases